Works matching IS 19466234 AND DT 2023 AND VI 15 AND IP 710

Results: 4
    1
    2

    A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19.

    Published in:
    Science Translational Medicine, 2023, v. 15, n. 710, p. 1, doi. 10.1126/scitranslmed.adi0252
    By:
    • Van Damme, Karel F. A.;
    • Hoste, Levi;
    • Declercq, Jozefien;
    • De Leeuw, Elisabeth;
    • Maes, Bastiaan;
    • Martens, Liesbet;
    • Colman, Roos;
    • Browaeys, Robin;
    • Bosteels, Cédric;
    • Verwaerde, Stijn;
    • Vermeulen, Nicky;
    • Lameire, Sahine;
    • Debeuf, Nincy;
    • Deckers, Julie;
    • Stordeur, Patrick;
    • Depuydt, Pieter;
    • Van Braeckel, Eva;
    • Vandekerckhove, Linos;
    • Guilliams, Martin;
    • Schetters, Sjoerd T. T.
    Publication type:
    Article
    3

    The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains.

    Published in:
    Science Translational Medicine, 2023, v. 15, n. 710, p. 1, doi. 10.1126/scitranslmed.adg6050
    By:
    • Sacconnay, Lionel;
    • De Smedt, Jonathan;
    • Rocha-Perugini, Vera;
    • Ong, Edison;
    • Mascolo, Romuald;
    • Atas, Anne;
    • Vanden Abeele, Carline;
    • de Heusch, Magali;
    • De Schrevel, Nathalie;
    • David, Marie-Pierre;
    • Bouzya, Badiaa;
    • Stobbelaar, Kim;
    • Vanloubbeeck, Yannick;
    • Delputte, Peter L.;
    • Mallett, Corey P.;
    • Dezutter, Nancy;
    • Warter, Lucile
    Publication type:
    Article
    4